Clinical trial protocol

TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10

Rugo HS, Schmid P, Cortes J, Takano T, Fasching PA, Park YH, Bianchini G, Franco SX, Villarreal-Garza C, Tredan O, Yin Y, Barroso-Sousa R, Peng[...]

By afschroeder • August 1, 2026

Inhaled sedation versus propofol in respiratory failure in the ICU (INSPiRE-ICU2): study protocol for a multicenter randomized controlled trial

O'Gara B, Serra AL, Englert JA, Sachdev A, Owens RL, Chang SY, Park PK, Talmor D, Sverud I, Sackey P, Beitler JR. Inhaled sedation versus[...]

By sjmartinez • April 1, 2025